on 27 Apr 2022
Last Applicant/ Owned by
CALCISCON AG
Aarbergstrasse 46
Biel/Bienne, , CH-2503
Serial Number
UK00003781758 filed on 27th Apr 2022
Registration Number
UK00003781758 registered on
22nd Jul 2022
Correspondent Information
Simmons & Simmons LLP
Citypoint, One Ropemaker Street
London,
EC2Y 9SS
Chemicals, in particular biochemical products, in particular reagents, in particular laboratory reagents, in particular products in kits for the identification and diagnosis of a calcification risk in patients, or for the identification and diagnosis of cardiovascular diseases in patients, or for the identification of a phosphate toxicity in patients; Products for the identification of a calcification in a human serum sample, in particular products comprising calcium and phosphate.
Pharmaceutical and veterinary products, in particular reagents and drugs; reagents and drugs for pharmaceutical uses, in particular products and kits for the identification and diagnosis of a calcification risk in patients, or for the identification and diagnosis of cardiovascular diseases in patients, or for the identification of a phosphate toxicity, in particular products for the identification of a calcification in a human serum sample, in particular products comprising calcium and phosphate, in particular for human medical use; Drugs for treating calcification, phosphate toxicity, or cardiovascular diseases in patients.
Medical apparatus and instruments, medical devices, medical analysis instruments, medical diagnosis instruments, diagnostic instruments for medical use, analytical instruments for medical use, in particular for the analysis, detection and treatment of calcification, phosphate toxicity, or cardiovascular diseases in patients.
Marketing, Product Marketing, Device Marketing, Database Marketing, online Marketing, in particular in the area of analysis and treatment of calcification, phosphate toxicity, or cardiovascular diseases.
Software as a service; Providing software and hardware for scientific use, analysis, diagnostics and treatment of calcification, phosphate toxicity, or cardiovascular diseases in patients; Design and development of computer hardware and software in the field of medical, scientific, diagnostic and therapeutic application related to the measurement, analysis and the treatment of calcification, or phosphate toxicity, or cardiovascular diseases in blood, especially in a human patient and human biologicals fluids including serum samples.
Consulting services in the fields of medicine, in particular human medicine, in particular consulting related to the risk of calcification of patients, or related to the risk of cardiovascular disease in patients, or to identify a phosphate toxicity; Consulting in the fields of health care and prevention; Providing information in the fields of health, health care, drugs and drug safety; Drug development, in particular for drugs treating calcification, phosphate toxicity, or cardiovascular diseases, in particular for use in human patients; Provision of diagnostic products in kits; Provision of pharmaceutical information; Medical consulting services related to therapy and diagnostics in individuals; Medical consulting services in the area of cardiovascular diseases in patients.
UK00003781758
Word
Individual